Volume: 7 Issue: 1
Year: 2019, Page: 79-84,
Introduction: Stroke is the second leading cause of mortality worldwide. Patients present with varied clinical presentations.
Objectives: To evaluate the clinical profile and radiological profile of ischemic stroke patients. To assess the outcome in relation to various clinical and radiological presentations using National Institutes of Health Stroke Scale (NIHSS).
Materials and Methods :This is a hospital based prospective cross sectional study done in Prathima Institute of Medical Sciences during the period from February 2016 to July 2016 which comprised of 150 patients.
Results :Stroke is most common as the age advances. Risk factor association is the main cause for development of stroke.
Conclusion ::NIHSS is helpful in identifying persons with stroke from those suspected to have stroke. Knowledge about identifying and reading radiological investigations will help in assessing the severity of stroke.
Keywords: Stroke Scale, Computed tomography scan, Ischemic heart disease.
1) Wolf PA, Cobb JL,D’Agostino RB.Epidemiology of stroke.In Barnett HJM,Mohr JP,Stein BM et al(eds).Strokepathophysiology,diagnosis and management.3rd ed.,Churchill Livingstone,New York,18;pp 3-28.
2) Dhanraj M.Acute cerebrovascular diseases.Orient Longman, Hyderabad, 14; pp 5.
3) Dalal PM, Malik S, Bhattacharjee M, Trivedi ND, Vairale J, Bhat P, et al. Population-based stroke survey in Mumbai, India: Inci¬dence and 28-day case fatality. Neuroepidemiology 2008; 31: 254-261.
4) Sridharan SE, Unnikrishnan JP, Sukumaran S, Sylaja PN, Nayak SD, Sarma PS, et al. Incidence, types, risk factors, and outcome of stroke in a developing country: The Trivandrum Stroke Registry. Stroke 2009; 40:1212-1218.
5) Das SK, Banerjee TK, Biswas A, Roy T, Raut DK, Mukherjee CS, et al. A prospective community-based study of stroke in Kolkata, India. Stroke 2007; 38:906-910.
6) Nagaraja D, Gururaj G, Girish N, Panda S, Roy AK, Sarma GR, et al. Feasibility study of stroke surveillance: Data from Banga¬lore, India. Indian J Med Res 2009; 130:396- 403.
7) National Institutes of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333:1581– 1587.
8) Haley EC, Lewandowski C, Tilley BC. Myths regarding NINDS rtPA Stroke Trial: setting the record straight. Am Emerg Med1997; 30: 676–682.
9) Schiemanck SK, Kwakkel G, Post MW, Prevo AJ. Predictive value of ischemic lesion volume assessed with magnetic resonance imaging for neurological deficits and functional outcome post stroke: A critical review of the literature. Neurorehabil Neural Repair 2006; 20:492.
10) Brott TG, Haley EC, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marler JR. Urgent therapy for stroke, part I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23:632-640.
11) Haley EC, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Tomer JC, Marler JR. Urgent therapy for stroke, part II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992; 23:641-645.
12) Saver JL, Altman H. Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset. Stroke 2012; 43:1537.
13) Frankel MR, Morgenstern LB, Kwiatkowski T, et al. Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology 2000; 55:952.
Bharathkanth Reddy M, Ranjith Kumar P.A clinico – radiological study of ischemic stroke in a tertiary care hospital in North Telangana. Perspectives in Medical Research 2019; 7(1):79-84.